Domača stranCONCORDBIO • NSE
add
Concord Biotech Ltd
Prejšnji trg. dan.
1518,60 ₹
Dnevni razpon
1478,20 ₹ - 1531,20 ₹
Letni razpon
1327,05 ₹ - 2664,00 ₹
Tržna kapitalizacija
155,70 mrd. INR
Povprečni obseg
70,06 tis.
Razm. P/E
40,35
Dividendna donosnost
0,59 %
Primarna borza
NSE
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (INR) | dec. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 2,44 mrd. | 1,42 % |
Stroški poslovanja | 806,93 mio. | −20,36 % |
Čisti dohodek | 759,21 mio. | −2,13 % |
Čista dobičkovnost prihodkov | 31,09 | −3,51 % |
Earnings per share | 7,26 | −2,02 % |
EBITDA | 976,51 mio. | −7,52 % |
Efektivna davčna stopnja | 24,94 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (INR) | dec. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 2,84 mrd. | 26,07 % |
Skupna sredstva | — | — |
Skupne obveznosti | — | — |
Celoten lastniški kapital | 15,90 mrd. | — |
Shares outstanding | 104,57 mio. | — |
Razmerje P/B | 9,99 | — |
Donosnost sredstev | — | — |
Donosnost kapitala | 13,28 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (INR) | dec. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 759,21 mio. | −2,13 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Datum ustanovitve
2000
Spletno mesto
Zaposleni
1.377
